Groups to Ala. Supreme Court: Reconsider generic-drugs decision

02/24/2013 | Wall Street Journal, The

Business groups led by the U.S. Chamber of Commerce and the Pharmaceutical Research and Manufacturers of America are pressing the Alabama Supreme Court to reconsider its ruling that makes brand-name drugmakers liable for injuries caused by generic versions of their treatments. "By essentially absolving [generic-drug-makers] of any responsibility, you're saying they don't have to perform that job very carefully," PhRMA General Counsel Mit Spears said. In a separate court brief, the Chamber of Commerce said the decision "threatens to unleash the plaintiffs' bar on all manufacturers doing business in Alabama" and "eviscerates basic tort limitations."

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI